Volver a Agendas
Session Chair(s)
Hideki Hanaoka, MD, PhD
Chiba University Hospital Clinical Research Center, Japan
Toshio Miyata, MD
Executive Director
Health and Global Policy Institute, Japan
Speaker(s)
Bayer’s R&D Partnering Models
Shunichi Takahashi, PhD
Bayer Yakuhin, Ltd., Japan
Director, Head of Open Innovation Center Japan
Introduction of The DSANJ System –Scientific-Based Trust-Cultivating System in The Drug-Discovery Stage in Japan-
Tohru Yoshikawa
Osaka Chamber of Commerce and Industry, Japan
Webmaster of DSANJ, Life Science Group, Economy and Industry Division
Goal to Reach for ARO in Japan
Mitsuhiro Okamoto, RPh
Takeda Pharmaceutical Company Limited, Japan
Associate Director, HR Development, Development Management Dept
Kazuhiro Momose
Astellas Pharma Inc., Japan
Senior Manager
¿Tiene una cuenta?